Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by bligickaon Mar 22, 2021 7:27pm
60 Views
Post# 32855466

RE:RE:RE:RE:2021 Reseach-Development-Strategy-Progress💯💥

RE:RE:RE:RE:2021 Reseach-Development-Strategy-Progress💯💥With their apparent level of expertise in infectious diseases they should've been able to predict the outcome of the experiment based on frequency and dosages....not come up completely void of any protective antibodies..... l don't believe the signal peptides will work period .....the vaxhit platform isn't worth a friggin dime at this point
CamaroZL1 wrote: It means it is not a vaccine YET. They need to adjust the formulation, assuming that is successful, antibodies will be present THEN. Its like building a house you can see the foundation and maybe the floor being installed. You cant live in it yet but you can see that it is a house and its being built. That help???


<< Previous
Bullboard Posts
Next >>